Tiange Lu

563 total citations
11 papers, 389 citations indexed

About

Tiange Lu is a scholar working on Molecular Biology, Rheumatology and Oncology. According to data from OpenAlex, Tiange Lu has authored 11 papers receiving a total of 389 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Rheumatology and 3 papers in Oncology. Recurrent topics in Tiange Lu's work include RNA modifications and cancer (2 papers), Inflammatory Myopathies and Dermatomyositis (2 papers) and Systemic Lupus Erythematosus Research (2 papers). Tiange Lu is often cited by papers focused on RNA modifications and cancer (2 papers), Inflammatory Myopathies and Dermatomyositis (2 papers) and Systemic Lupus Erythematosus Research (2 papers). Tiange Lu collaborates with scholars based in Australia, United Kingdom and China. Tiange Lu's co-authors include David Isenberg, Kristine Ng, Jonathan Edwards, Michael R. Ehrenstein, Maria Leandro, Geraldine Cambridge, Stefan Schreiber, Jochen Hampe, Andreas Wollstein and Matthew J. Will and has published in prestigious journals such as Bioinformatics, Journal of Hematology & Oncology and Lara D. Veeken.

In The Last Decade

Tiange Lu

11 papers receiving 368 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tiange Lu Australia 7 202 165 102 69 63 11 389
G Sturfelt Sweden 9 282 1.4× 246 1.5× 61 0.6× 54 0.8× 59 0.9× 10 434
Viviana Antonella Pacucci Italy 9 302 1.5× 208 1.3× 92 0.9× 53 0.8× 71 1.1× 17 466
Samy Metyas United States 6 289 1.4× 344 2.1× 150 1.5× 37 0.5× 70 1.1× 6 492
Z S Alekberova Russia 12 240 1.2× 208 1.3× 158 1.5× 43 0.6× 131 2.1× 69 543
Anum Fayyaz United States 3 180 0.9× 120 0.7× 37 0.4× 51 0.7× 31 0.5× 7 348
GR Burmester Germany 10 310 1.5× 248 1.5× 66 0.6× 42 0.6× 50 0.8× 28 495
Haraldine A. Stafford United States 12 305 1.5× 327 2.0× 218 2.1× 48 0.7× 63 1.0× 22 578
Konstantia-Maria Chavele United Kingdom 6 122 0.6× 266 1.6× 42 0.4× 23 0.3× 75 1.2× 7 399
S A Bell Germany 7 130 0.6× 148 0.9× 51 0.5× 71 1.0× 52 0.8× 8 312
Isaac Abadi Venezuela 8 349 1.7× 247 1.5× 78 0.8× 58 0.8× 25 0.4× 9 435

Countries citing papers authored by Tiange Lu

Since Specialization
Citations

This map shows the geographic impact of Tiange Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tiange Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tiange Lu more than expected).

Fields of papers citing papers by Tiange Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tiange Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tiange Lu. The network helps show where Tiange Lu may publish in the future.

Co-authorship network of co-authors of Tiange Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Tiange Lu. A scholar is included among the top collaborators of Tiange Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tiange Lu. Tiange Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Liu, Bingyu, et al.. (2025). CAR-NK cell therapy: latest updates from the 2024 ASH annual meeting. Journal of Hematology & Oncology. 18(1). 22–22. 7 indexed citations
3.
Chen, Xiaohong, et al.. (2023). Targeting YTHDF2 inhibits tumorigenesis of diffuse large B-cell lymphoma through ACER2-mediated ceramide catabolism. Journal of Advanced Research. 63. 17–33. 20 indexed citations
4.
Lu, Tiange, et al.. (2017). Amitriptyline modulated Ca2+ signaling and induced Ca2+-independent cell viability in human osteosarcoma cells. Human & Experimental Toxicology. 37(2). 125–134. 2 indexed citations
6.
Lu, Tiange, Kristine Ng, Geraldine Cambridge, et al.. (2009). A retrospective seven‐year analysis of the use of B cell depletion therapy in systemic lupus erythematosus at university college london hospital: The first fifty patients. Arthritis Care & Research. 61(4). 482–487. 201 indexed citations
7.
Roberts-Thomson, P J, Jenny Walker, Tiange Lu, et al.. (2006). Scleroderma in South Australia: further epidemiological observations supporting a stochastic explanation. Internal Medicine Journal. 36(8). 489–497. 39 indexed citations
8.
Lu, Tiange, Richard Kwiatek, & Vidya Limaye. (2006). Intravenous pamidronate in the treatment of sternoclavicular hyperostosis. APLAR Journal of Rheumatology. 9(3). 290–293. 1 indexed citations
9.
Lu, Tiange, et al.. (2005). Profound weight loss associated with reboxetine use in a 44‐year‐old woman. British Journal of Clinical Pharmacology. 60(2). 218–220. 6 indexed citations
10.
Lu, Tiange & P J Roberts-Thomson. (2005). Inflammatory myositis in systemic sclerosis: a South Australian perspective. APLAR Journal of Rheumatology. 8(3). 198–202. 2 indexed citations
11.
Hampe, Jochen, et al.. (2001). An integrated system for high throughput TaqMan™ based SNP genotyping. Bioinformatics. 17(7). 654–655. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026